The World Health Organization (WHO) has finally admitted that despite all of the hysteria, nobody has died of the Omicron variant of COVID-19.
The WHO issued a warning stating that it may take several weeks for experts to figure out how infectious this new variant is, and how effective both jabs and other treatments are against it.
“‘We’re going to get the answers that everybody out there needs,” said WHO emergencies director Michael Ryan, according to Daily Mail.
International Monetary Fund chief Kristalina Georgieva spoke out yesterday to claim that much like the Delta variant did, the Omicron variant could slow the global economic recovery.
“Even before the arrival of this new variant, we were concerned that the recovery, while it continues, is losing somewhat momentum,” she said. “A new variant that may spread very rapidly can dent confidence.”
Health Secretary Sajid Javid said that he had a “productive” meeting with the World Health Organization’s director-general Tedros Adhanom Ghebreyesus today.
“Productive meeting with @DrTedros and his team to share our findings so far on Omicron,” Javid tweeted. “We continue to work with @WHO on our global treaty to prepare for and respond to future pandemics, and on building a global surveillance network.”
The U.S. and Australia became the latest countries this week to confirm that cases of the Omicron variant were being transmitted locally. On Friday, New Jersey, Maryland, Missouri, Nebraska, Pennsylvania and Utah each reported their first cases of the Omicron variant.
“We do see an increasing growth rate, we see increasing numbers of omicron being detected,” said Maria Van Kerkhove, the WHO’s Covid-19 technical lead, according to CNBC. “But we have reports of omicron in 38 countries in all six WHO regions. There is a suggestion that there is increased transmissibility, what we need to understand is if it’s more or less transmissible compared to Delta.”
Dr. Mike Ryan, executive director of the WHO’s health emergencies program, said “clearly the virus does appear to be transmitting efficiently. And we saw that before with Delta. So again, there’s certain things we shouldn’t be surprised with.”
However, Van Kerkhove reiterated that it is still far too early to figure out just how dangerous the Omicron variant is.
“There was initial reports that it tended to be more mild, but it’s really too soon,” Van Kerkhove said. “Everybody who is infected with SARS-CoV-2 regardless of what variant will always start out with a mild disease. And so maybe it will stop there with mild, some people are asymptomatic of course, but it may stop with mild disease or it may take some time.”
Red Voice Media would like to make a point of clarification on why we do not refer to any shot related to COVID-19 as a "vaccine." According to the CDC, the definition of a vaccine necessitates that said vaccine have a lasting effect of at least one year in preventing the contraction of the virus or disease it's intended to fight. Because all of the COVID-19 shots thus far available have barely offered six months of protection, and even then not absolute, Red Voice Media has made the decision hereafter to no longer refer to the Pfizer, Moderna, or Johnson & Johnson substances as vaccinations.